Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05691309 · ClinicalTrials.gov registry record
Optimizing Vancomycin Therapy in Children
A clinical trial, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- 29
- Enrollment target
NCT05691309 is a clinical trial that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 29 participants.
The verdict
NCT05691309 has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
The purpose of Opt Vanc is to evaluate the feasibility of Bayesian dose adaptation, based on a previously-developed population pharmacokinetic (PK) model and a single optimally timed PK sample, to predict vancomycin area under the curve (AUC) in critically ill children.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2022-12-12 |
| Est. Completion | 2023-11-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05691309
The ClinicalTrials.gov registry entry for NCT05691309 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05691309 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05691309 about?
NCT05691309 is a clinical study titled "Optimizing Vancomycin Therapy in Children". The purpose of Opt Vanc is to evaluate the feasibility of Bayesian dose adaptation, based on a previously-developed population pharmacokinetic (PK) model and a single optimally timed PK sample, to predict vancomycin area under the curve (AUC) in critically ill children.
What is the current status of trial NCT05691309?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2022-12-12. Estimated completion is 2023-11-22.
Who is sponsoring clinical trial NCT05691309?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.